News

Mesoblast (Nasdaq: MESO) has confirmed that its allogeneic cellular products, including Ryoncil® and Revascor®, will be exempt from U.S. tariffs. This exemption is made possible because the company’s products are designated as “U.S. Country of Origin” products. All products are manufactured using U.S. donors …

Telix Pharmaceuticals (ASX/NASDAQ: TLX) has appointed Anne Whitaker as a Non-Executive Director, effective April 7, 2025. Whitaker's appointment brings a wealth of knowledge and experience to the company, stemming from over three decades in the pharmaceutical, biotech, and specialty pharmaceutical sectors.

U.S. stock futures extended sharp losses Friday, with the S&P 500 and Dow down about 2.5% and Nasdaq 100 off 2.8%, deepening the recent sell-off that pushed the S&P into correction territory. The decline follows China’s retaliatory 34% tariff on U.S. imports, escalating the …

Dow and S&P 500 futures fell over 2% and 3%, respectively, while Nasdaq 100 futures plunged more than 4%. Companies with global supply chains suffered sharp declines, with Apple down 7.5%, Nike 7%, and Tesla 7.2%. Mega-cap tech stocks and retailers also saw significant …

Novartis has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Vanrafia® (atrasentan), a potent and selective endothelin A (ETA) receptor antagonist, for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) who are at high …

PVH Corp. (NYSE:PVH), the parent company of Calvin Klein and Tommy Hilfiger, posted better-than-expected Q4 earnings, despite a 5% year-over-year revenue decline. The company also unveiled plans for a $500 million share repurchase program.

Johnson & Johnson (NYSE:JNJ) suffered a significant legal blow on Tuesday, as a Texas bankruptcy judge rejected its $10 billion proposal to resolve thousands of lawsuits alleging its talc-based baby powder caused cancer. The ruling sent J&J’s stock tumbling 7.6%, closing at $153.25.